NCT01351350View on ClinicalTrials.gov

Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

September 15, 2017

Study Completion Date

September 15, 2017

Conditions
Advanced Solid MalignanciesHematologic Malignancies
Interventions
DRUG

MLN0128

MLN0128 capsules

DRUG

paclitaxel

paclitaxel intravenous infusion

DRUG

trastuzumab

trastuzumab intravenous infusion

Trial Locations (3)

33905

Fort Myers

37203

Nashville

73104

Oklahoma City

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY